Patents matching “LTD.”

US 11814394

Exatecan derivatives, linker-payloads, and conjugates and thereof

GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Nov 14, 2023 · Expires Nov 9, 2043

US 11814657

Modified DNase and uses thereof

Protalix Ltd. · Granted Nov 14, 2023 · Expires Nov 9, 2043

US 11806421

Porous-cellulose particles and production method thereof, and cosmetic

JGC Catalysts and Chemicals Ltd. · Granted Nov 7, 2023 · Expires Nov 2, 2043

US 11801265

Preparation method of NK cells and use thereof in the treatment of cancer

SINO UNITED (BEIJING) BIOMEDICAL TECHNOLOGY CO., LTD. · Granted Oct 31, 2023 · Expires Oct 26, 2043

US 11793776

Methods of administering solriamfetol to lactating women

AXSOME MALTA LTD. · Granted Oct 24, 2023 · Expires Oct 19, 2043

US 11786539

Aminoglycoside derivatives and uses thereof in treating genetic disorders

ELOXX PHARMACEUTICALS LTD. · Granted Oct 17, 2023 · Expires Oct 12, 2043

US 11786541

Inhibitor of sphingosine kinase 2 for treating Ebola

RedHill Biopharma Ltd. · Granted Oct 17, 2023 · Expires Oct 12, 2043

US 11779625

Composition and application thereof in preparing product for protecting mitochondria

INFINITUS (CHINA) COMPANY LTD. · Granted Oct 10, 2023 · Expires Oct 5, 2043

US 11779554

Methods of administering solriamfetol to lactating women

AXSOME MALTA LTD. · Granted Oct 10, 2023 · Expires Oct 5, 2043

US 11780805

Carbamoyl phenylalaninol compounds and uses thereof

AXSOME MALTA LTD. · Granted Oct 10, 2023 · Expires Oct 5, 2043

US 11771666

Methods of administering solriamfetol to lactating women

AXSOME MALTA LTD. · Granted Oct 3, 2023 · Expires Sep 28, 2043

US 11771667

Methods of administering solriamfetol to lactating women

AXSOME MALTA LTD. · Granted Oct 3, 2023 · Expires Sep 28, 2043

US 11753377

Crystal form of 2-methyl-2-propanol and amino-substituted aryl compound

ZHUHAI UNITED LABORATORIES CO., LTD. · Granted Sep 12, 2023 · Expires Sep 7, 2043

US 11717565

Recombinant BCG overexpressing phoP-phoR

LTD. · Granted Aug 8, 2023 · Expires Aug 3, 2043

US 11717576

Antibody-immune agonist conjugate and applications thereof

GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Aug 8, 2023 · Expires Aug 3, 2043

US 11713292

Treatment of cataplexy

AXSOME MALTA LTD. · Granted Aug 1, 2023 · Expires Jul 27, 2043

US 11701307

Organic-inorganic composite particles, manufacturing method therefor, and cosmetic

JGC Catalysts and Chemicals Ltd. · Granted Jul 18, 2023 · Expires Jul 13, 2043

US 11679143

FGF21 variant, fusion protein and application thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Jun 20, 2023 · Expires Jun 15, 2043

US 11672749

Peptide exhibiting wrinkle-improving activity and uses thereof

CAREGEN CO., LTD. · Granted Jun 13, 2023 · Expires Jun 8, 2043

US 11668704

Degradation preventing means for immunoassay reagent containing insoluble carrier particles

Fujikura Kasei Co., Ltd. · Granted Jun 6, 2023 · Expires Jun 1, 2043

US 11667717

Antibodies binding to human IL-4R, preparation method therefor and use thereof

SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Jun 6, 2023 · Expires Jun 1, 2043

US 11660327

Methods and compositions for oral administration of proteins

Oramed Ltd. · Granted May 30, 2023 · Expires May 25, 2043

US 11654097

Peptide having activities of skin whitening and uses thereof

CAREGEN CO., LTD. · Granted May 23, 2023 · Expires May 18, 2043

US 11648232

Methods and compositions for treating excessive sleepiness

AXSOME MALTA LTD. · Granted May 16, 2023 · Expires May 11, 2043